Determining patient's coagulation profile, ie detecting a bleeding tendency or the opposite, a
thrombotic risk, is crucial for clinicians in many situations. Routine coagulation assays and …

Coronavirus disease 2019 (COVID-19)-associated coagulopathy (CAC), characterized by
hypercoagulability and an increased risk of thrombotic complications, is an important …

Objective: Coronavirus disease 2019 (COVID-19) is associated with derangement in
biomarkers of coagulation and endothelial function and has been likened to the …

Background Coagulation abnormalities in COVID-19 patients have not been addressed in
depth. Objective To perform a longitudinal evaluation of coagulation profile of patients …

Coronavirus disease 2019 (COVID-19) is associated with marked albeit variable hemostasis
disturbances and high thrombotic risk [1]. Measurement of plasma D-dimers levels has been …

Direct endothelial injury by viruses and dysregulation of clotting mechanisms due to cytokine
storm are the major precipitating factors of mortality in COVID-19; both are attributed to a …

Hemostatic unbalance is often observed in patients with coronavirus disease 2019 (COVID-
19), and patients with severe disease are at high risk of developing thromboembolic …

Abstract Background Anti-Xa assays are used for unfractionated heparin (UFH) monitoring.
Dextran sulfate (DS) is used in some assays to overcome the artifactual preanalytical …

Patients admitted to the intensive care unit (ICU) with coronavirus disease 2019 (COVID-19),
the infectious pathology caused by severe acute respiratory syndrome coronavirus 2, have a …

Heparins, unfractionated or low molecular weight, are permanently in the spotlight of both
clinical indications and laboratory monitoring. An accurate drug dosage is necessary for an …